Skip to main content
TipRanks
Go Ultimate75% OFF

MYUNGMOON Pharm Co., Ltd. (017180) Stock Statistics & Valuation Metrics

Total Valuation

MYUNGMOON Pharm Co., Ltd. has a market cap or net worth of KRW 34.00B. The enterprise value is KRW 128.25B.

Market Cap
KRW 34.00B
Enterprise Value
KRW 128.25B

Share Statistics

MYUNGMOON Pharm Co., Ltd. has 33,953,453 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
33,953,453
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

MYUNGMOON Pharm Co., Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.58%.

Return on Equity (ROE)
0.02
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
1.58%
Return on Capital Employed (ROCE)
0.04
Revenue Per Employee
631.87M
Profits Per Employee
6.13M
Employee Count
309
Asset Turnover
0.72
Inventory Turnover
2.27

Valuation Ratios

The current PE Ratio of MYUNGMOON Pharm Co., Ltd. is -2.68. MYUNGMOON Pharm Co., Ltd.’s PEG ratio is -0.01.

PE Ratio
-2.68
PS Ratio
0.17
PB Ratio
0.40
Price to FCF
-1.30
Price to Operating Cash Flow
-2.10
PEG Ratio
-0.01

Income Statement

In the last 12 months, MYUNGMOON Pharm Co., Ltd. had revenue of 195.25B and earned 1.90B in profits. Earnings per share was 56.70.

Revenue
195.25B
Gross Profit
107.19B
Operating Income
6.83B
Pretax Income
2.65B
Net Income
1.90B
EBITDA
10.13B
Earnings Per Share (EPS)
56.70

Cash Flow

In the last 12 months, operating cash flow was -16.48B and capital expenditures -10.06B, giving a free cash flow of -26.54B billion.

Operating Cash Flow
-16.48B
Free Cash Flow
-26.54B
Free Cash Flow per Share
-781.57

Dividends & Yields

MYUNGMOON Pharm Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-76.85%
Earnings Yield
-36.36%

Stock Price Statistics

Beta
0.03
52-Week Price Change
-42.08%
50-Day Moving Average
1223.20
200-Day Moving Average
1450.36
Relative Strength Index (RSI)
22.25
Average Volume (3m)
183.27K

Important Dates

MYUNGMOON Pharm Co., Ltd. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Mar 24, 2027
Ex-Dividend Date
―

Financial Position

MYUNGMOON Pharm Co., Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 99.89%

Current Ratio
0.96
Quick Ratio
0.55
Debt to Market Cap
1.56
Net Debt to EBITDA
9.16
Interest Coverage Ratio
1.34

Taxes

In the past 12 months, MYUNGMOON Pharm Co., Ltd. has paid 1.23B in taxes.

Income Tax
1.23B
Effective Tax Rate
0.46

Enterprise Valuation

MYUNGMOON Pharm Co., Ltd. EV to EBITDA ratio is -31.36, with an EV/FCF ratio of -4.39.

EV to Sales
0.59
EV to EBITDA
-31.36
EV to Free Cash Flow
-4.39
EV to Operating Cash Flow
-7.07

Balance Sheet

MYUNGMOON Pharm Co., Ltd. has KRW 6.05B in cash and marketable securities with KRW 87.54B in debt, giving a net cash position of -KRW 81.49B billion.

Cash & Marketable Securities
KRW 6.05B
Total Debt
KRW 87.54B
Net Cash
-KRW 81.49B
Net Cash Per Share
-KRW 2,399.99
Tangible Book Value Per Share
KRW 2,668.30

Margins

Gross margin is 58.69%, with operating margin of -3.64%, and net profit margin of -6.32%.

Gross Margin
58.69%
Operating Margin
-3.64%
Pretax Margin
-6.17%
Net Profit Margin
-6.32%
EBITDA Margin
-1.87%
EBIT Margin
-3.64%

Analyst Forecast

The average price target for MYUNGMOON Pharm Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
2.66%
EPS Growth Forecast
-947.63%

Scores

Smart Score
―
AI Score
43